HERON THERAPEUTICS, INC.
HRTX · NASDAQ
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.
Market Data
Price
$1.20
+0.01 (+0.84%)
Market Cap$222M
P/E Ratio—
EPS$—
52W High$2.61
52W Low$0.74
Beta1.68
Data from Finnhub · Updated May 1, 2026